Continuing the epidemiological function of the addicts index—evidence from matching the home office addicts index with the National Drug Treatment Monitoring System

2004 ◽  
Vol 11 (2) ◽  
pp. 91-100 ◽  
Author(s):  
Matthew Hickman ◽  
Maria Griffin ◽  
Joy Mott ◽  
John Corkery ◽  
Peter Madden ◽  
...  
2009 ◽  
Vol 36 (3-4) ◽  
pp. 663-684
Author(s):  
Martin Chandler ◽  
Jim McVeigh ◽  
Caryl Beynon

The Centre for Public Health at Liverpool John Moores University houses a number of distinct, but related, systems that collate attributable monitoring data from drug treatment, criminal justice, and harm reduction services in the North West of England. Briefly, the National Drug Treatment Monitoring System collates data from higher level structured drug treatment services (e.g., substitute prescribing, psychological interventions, and abstinence-based programs), while the Drug Interventions Programme collects data on criminal justice interventions both within the community and prisons, which aim to divert offenders into treatment. Alcohol treatment services for the region are monitored through the Alcohol Treatment Monitoring System. These systems provide regular reports to key stakeholders as well as themed reports to respond to specific public health and commissioning needs. These data are also used to demonstrate client crossover and pathways between services and regional trends in substance use. Finally, the data facilitate investigations into diverse drug-related issues such as injecting behavior, drug-related deaths, modeling to determine hidden drug using populations, epidemiological investigations, changing drug treatment demands, and monitoring the impact of government policy. In combination, these monitoring systems contain information relating to over 100,000 individuals in the North West of England over a 12-year period.


Author(s):  
Paul J. Turnbull ◽  
Tim McSweeney ◽  
Russell Webster ◽  
Mark Edmunds ◽  
Mike Hough

Author(s):  
Maeve Haran ◽  
John R. Kelly ◽  
Liam Kennedy ◽  
Kieran Hennigan ◽  
Huma Farid ◽  
...  

Author(s):  
Marcelo León ◽  
Maritza Ruíz ◽  
Lídice Haz ◽  
Robert Montalvan ◽  
Viviana Pinos Medrano ◽  
...  

1993 ◽  
Vol 10 (3) ◽  
pp. 162-163 ◽  
Author(s):  
Eamon Keenan ◽  
Maurice Gervin ◽  
Arthur Dorman ◽  
John J O'Connor

AbstractA seventeen year old man attended the National Drug Treatment Centre with a paranoid psychosis following ingestion of Methylene dioxy methamphetamine (MDMA). He had been taking MDMA on a recreational basis over a five month period. Although chronic psychosis after heavy use of MDMA has been reported there are no pervious reports of psychosis following recreational use. This report highlights the psychological dangers of this drug, which has become widely misused in Dublin over the last two years.


2011 ◽  
Vol 26 (S2) ◽  
pp. 1826-1826 ◽  
Author(s):  
R. Perez-Montejano ◽  
E. Finch ◽  
K. Wolff

IntroductionOver the last decade a series of guidelines and recommendations have been published in the UK by the Department of Health, the Home Office, Professional and Non-Professional bodies. However, an optimal strategy and consensus in the management and care of opioid dependent pregnant users has yet to be established.ObjectivesDetermination of existing methods for identifying and managing pregnancy in opioid users prescribed methadone by NHS Treatment Services and regional differences.AimTo survey the management, treatment and follow-up of pregnant opioid users prescribed methadone by Drug Treatment Services in England and Wales.MethodsIn 2006 a POSTAL survey was conducted among 223 Community Drug Treatment Services (CDTS).ResultsSixty-six percent of CDTS responded to the survey (n = 154/233). A Chi-square, Mann_Whitney U Test and/or Kruskal-Wallis analysis revealed significant differences in the composition of CDTS and service provision across regions. Half of CDTS (55.3%) provided a methadone dosage regime lower than that recommended for non-pregnant drug users. There were also significant variations on how professionals approached the management of pregnant opioid users. CDTS with an addiction specialist were significantly more likely (p < .01) to advocate high doses of methadone whereas those with a midwife, obstetrician or social worker involved were more likely (p < .05) to suggest low dose methadone and/or detoxification.ConclusionsService provision for pregnant opioid users is comprehensive but there is still variability in some aspects of the treatment received. The way in which methadone is prescribed is not always optimal. Further work is required in this area.


2016 ◽  
Vol 118 ◽  
pp. S92
Author(s):  
V. Rosso ◽  
G. Battistoni ◽  
N. Belcari ◽  
N. Camarlinghi ◽  
G.A.P. Cirrone ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document